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INTRODUCTION 
The appearance in the world literature of increasing num-
bers of reports dealing with studies of human enzyme determin-
ations attests to the importance experimenters and clinicians 
alike are ascribing to enzymology. Zimmermann (96) states: 
1 
"Enzymology, which was born a century ago, has grown vigorously 
during the past few decades. More than 700 organic catalysts have 
been identified in the tissues of living organisms. Approximately 
50 of these enzymes have been identified in the plasma to which 
they {,L.in access from injured cells, or perhaps from intact cells. 
Interest of clinicians in serum enzymes began over 30 years ago 
with the demonstrated diagnostiC usefulness of alkaline and acid 
phosphatase, and amylase levels. Despite the clinical usefulness 
of these Darameters of disease and the demonstration, during the 
next two decades of a number of other enzymes in the serum, clin-
ical and investigative interest in serum enzymology remained spo-
radic until 1953. The demonstration in that year of a transaminase 
in normal serum and the subsequent observations that increased levels 
of this enzyme faithfully reflect disease of the heart, liver, and 
other organs, led to an explosive increase in interest in serum 
enzymes. 
"The use of serum enzymes as diagnostic aids has been largely 
empirical, but the values observed in clinical and experimantal 
circumstances permit speculative analysis of the factors that con-
trol serum enzyme levels in normal and diseased subjects. Enzyme 
levels are determined as 'activity' rather than 'amount' of enzyme 
protein, because the relative concentration of coenzymes, poten-
tia tors, and inhi. bi tors may modify the apparent level ........ An 
-
elegant development in serum enzymology has been the effort to 
distinguish the tissue of origin of a serum enzyme which is 
ubiquitously distributed in tissue by studying its isoenzymes,," 
2 
\'Vi th thi,s brief historical background of enzymology in general, 
and the reference to the recent development of isoenzymology, in the 
lines that follow will be a closer examination of the different 
molecular forms of a particular functional enzyme, lactic dehydro-
genase (LDH) .. 
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DEFINITION, STRUCTURE AND CHEMICAL ACTIVITY 
Markert (39), in reviewing the literature, noted that the 
following enzymes exist in separate molecular forms within single 
specific tissues: esterase, ribonuclease, pepsin, chymotrypsin, 
trypsin, lysozyme, cytochrome C, xanthine dehydrogenase, malate 
dehydrogenase, and lactic dehydrogenase. Because of this, the 
various investigators noted a need to extend the classification of 
enzymes beyond that based on substrate specificity alone. They 
proposed the term 'isozyme' to describe the different molecular 
forms in which proteins may exist with the same enzymatic specificity. 
In the process of glycolysis lactic dehydrogenase (LDH) is the 
enzyme which facilitates in a reversible manner the conversion of 
lactate to pyruvate and the concomitant conversion of diphospho-
pyridine nucleotide (DPN) to reduced DPN (DPNH). Since glycolysis 
is a function carried on by all living cells, LDH is present in 
these same cells, although its concentration may vary widely from 
tissue to tissue. 
One of the earliest reports of discovery of the multiple molec-
ular forms of LDH came in 1950 when Meister (44) observed in the 
electrophoresis of crystalline beef-heart lactic dehydrogenase, a 
faster moving component (A), to which he accounted the whole enzymic 
activity, and also a slower moving one that amounted to about 15%. 
In 1957 Sayre (64) postulated that "LDH may consist of a single molec-
ular species which can be observed as a number of components repre-
senting different states of aggregation as a result of sulfhydryl or 
other urotein interactions~ In the same year Vesell (76) reported 
finding three peaks of LDH activity in electrophoretically sep-
arated human sera. 
Most workers are now agreed that there are five electrophor-
etically distinct forms of LDR, which are numbered according to their 
rates of electronhoretic migration. Some workers designate the 
fastest (+) migrating fraction (heart fraction) LDR-l and the slow-
est (-) (liver, skeletal muscle) LDH-5, while others utilize the 
reverse designation. This has added great confusion to the subject. 
For purposes of clarity this paper will adhere to the nomenclature 
recommended by the subcommittee on isoenzymes of the international 
Union: "when multiple forms of an enzyme are identified by electro-
phoretic separation, they should be given consecutive numbers, the 
form having the highest mobility towards the anode being nu.1!lbered 
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Figure 1. Electropherogram illustrating LDH 
isoenzyme nomenclature. (After Batsakis)(4). 
Markert and Appella (38) studied two main electrophoretic bands 
and found the constituents of each had a molecular weight of 134,000. 
This was later confirmed bv others (16,84). The two bands differed 
slightly in their Michaelis-Menton constants, charge per molecule 
and isoelectric pnints. 
Cahn and associates (9) reported that most vertebrates have two 
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chief categories of T,DH--one predominates in heart, the other in 
muscle4 In starch gel electrophoresi s the most posi ti vely moving 
portion is the heart type, the most negatively moving the muscle 
type. These two types were found to have widely differing amino 
acid composition (9, 16), electrophoretic mobility on starch grain 
and gel, substrate inhibition kinetics and analog oxidation ratio, 
and they were found to elicit antibodies in the rabbit that were 
non-cross reactive (9). 
The fact that only five bands are found in most well-documented 
careful studies suggested there must be some fundamental significance 
in this number, which could be explained by the following hypothesis: 
LDH from heart is a tetramer, composed of four identical subunits 
(HERR); LDR from muscle is also a tetramer, composed of four iden-
tical subunits (1~~~). Rand M are probably elaborated by two dif-
ferent genes. If both Rand M genes are active in the same cell, 
then the primary gene products recombine in some manner in groups of 
four, yielding five different molecular species: HRRR, RHRM, HR!rr~f 
H~,1lJ\f[M, and MIV!MM. The order of arrangement only affects the antigenic 
specificity--the subunits all act independently with respect to sub-
strate inhibition and rate of reaction with DPN analogs. This explains 
the five bands (9, 16, 40, 58, 65). Some of these same workers (2,9) 
found that one of the isoenzymes from crystalline LDH prepared from 
beef heart could be dissociated into four inactive subunits of equal 
molecular weight (34,000 .:t 2,000) by treatment with guanidine hydro-
chloride. This lent further sup:)ort tetramer hypothesis. Later, 
Markert (40) showed that a tetramer could be dissociated into mono-
mers by freezing in 1 M NaCl; on thawing, reassociation into five 
functional tetramers in the expected proportions of 1:4:6:4:1 occurred .. 
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Further su:)port of this hypothesis came from Nance and a~-::\socia tes (45) 
in the study of a Brazilian fa,nily whose members were found to have an 
erythrocyte LDR abnormality, all readily explainable by assuming a 
point mutation leading to an alteration of polypeptide chain M. 
Sub-bands of LDR isoenzymes have been artificially produced 
(17,37,58) by various chemical means and the explanation of their 
production also lends SUP90rt to the tetrameric hypothesis of L~R 
isoenzyme composition. 
Antigenic properties were investigated by several workers (21, 
46,52). Plagemann and associates (52) demonstrated antibody to 
rabbit LDH-l inhibited only trace amounts of LDR-5, and the isoenzymes 
intermediate between the slow and fast migrating forms were inhibited 
to an intermediate degree. Gregory and associates (21) demonstrated 
selective inhibition of glycolysis by antibody to LDH in homogenates 
of rabbit liver, rabbit Vx-2 carcinoma and mouse Ehrlich ascites 
carcinoma. Sodium oxamate was also shown to inhibit LDR in both an-
aerobic and aerobic glycolysis. Ng and associates (46) demonstrated 
an anti-LDR which inhibited glycolysis and protein synthesis in 
tumor culture cells but not in normal tissue cells, suggesting that 
their anti-LDH may have been selective for malignant cells. 
Biochemical studies (1) have demonstrated that various isoen-
zymes differed in their capacity to oxidize I-lactic acid, d-J.actic 
acid, d-l-o\-hydroxy butyric acid, d-I-j)(.-hydroxy caproic acid and 
d-l-~-hydroxy valerie acid. 
The techniaues USe -,or identifying the LDH isoenzymes have in-
cluded the electrophoretic rate of migration in solid media and the 
relative heat stability_ Electrophoretic demonstration of isoenzyme· 
activity is accomplished by conversion of neotetrazolium to purple 
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Figure 2. Schematic representation of the reactions 
involved in localizing LDH isoenzymes after they have 
been separated by electrophoresis in a starch gel. 
(After 1&lrkert)(39). 
formazin by LDH production Qf DPNH, as illustrated in Figure 20 
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Wroblewski (88) reported that the LDH from human heart muscle 
apneared to be more heat-stable than LDH from other tissues, and went 
on to propose a simple heat-stable test for isoenzymes. He found 
that ~DH-5 was almost entirely inactivated after incubation at 57°C 
for 30 minutes; LDH-l was not inactivated after incubation at 65°C 
for 30 minutes; and that intermediate forms of LDH were inactivated 
after incubation at 65°C for 30 minutes. Actual enzyme activity 
determinations are made by recording the rate of change in the 
characteristic absorption spectrums of reduced DPN at 340 mu. This 
activity may either be measured by the declining optical density as 
DPNH is diminishing and pyruvic acid concomitantly is being reduced 
to lactic acid, or by the increasing optical density as DF~h is in-
creasing 1 and the lactic acid concomitantly is being oxidized to 
8 
pyruvic acid. The former reaction is favored by the equilibrium of 
the system, but the latter reaction permits the use of more stable 
reagents.(5) Strandjord and associates (71) also propose utilizing 
the heat-stability test for diagnosis of certain disease states. 
Isoenzyme activity may also be altered by cold temperatures,as 
Zondag (97) found a total loss of activity in the slower moving 
o 
isoenzymes when the specimens were stored at -20 C under certain 
conditions. 
SERuM AND TISSUE PATTERNS OF LDH ISOENZYJvIES 
An interesting facet of LDH isoenzymes is the fact that 
each tissue :in the body'elaborates these multiple molecular forms 
in its own unique pattern; this discovery has been renorted by 
numerous workers. (12, 13, 14, 16, 34, 51, 53, 54, 55, 61, 70, 
77, 84, 85, 87, 88, 90, 92) Pfleiderer(5l) found through study 
of extracts of numerous human organs of different age that in 
the early stage of life all tissues show nearly the same dis-
tribution, exhibiting a m~um of activity in Band 3, and that 
during their development a change to the state of the adult 
tissues occurs. Cahn and associates (9) reported that during 
embryonic development the LDH enzymes of chicken breast muscle 
shift from enzymes related to H type (LDH-I) through several 
intermediate enzyme types and appear in the adult as pure M 
type (LDH-5). 
The predominance of LDH-l in aerobically functioning tissues 
and the predominance of LDH-5 in anaerobically functioning tiss-
ues was noted by Cahn and associates (9), Pfleiderer and Wachsmuth 
(50) and Fondy and Kaplan (16)~ and led to the formulation of a 
hypothesis that the predominance of LDH-5 in anaerobically met-
abolic tissues was due to its better efficiency in high con-
centrations under those conditions thEn LDH-l. Goldman (18) 
states that LDH-5 is better able to convert pyruvate to lactate 
in the presence of high pyruvate concentration, thus sustaining 
glycolytic activity through the replenishment of NAD, which is 
required as a hydrogen acceptor in the earlier oxidation of 
triosephosphate. Research of others indicate the only pathway 
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in malignant tumors for non-mitocyondrine oxidation of reduced 
IlIAD formed from the oxidation of triosephospha te may be through 
pyruvate reduction. There appears to be a change in LDll type 
to an enzyme which is geared for pyruvate reduction. In aerobic 
tissues where high substate concentrations do not develop, LDH-l 
performs more efficiently. Studies of malignant cells show a 
characteristic high rate of aerobic glycolysis resulting in high 
rates of lactic acid production.(16~ 18, 19, 20, 22, 61) Graff 
and associates(20), found that tumor culture cells resort to 
glycolysis only when the extracellular glucose concentration 
exceeds a threshold level of approximately 5 mg% or less, and 
become consumers, rather than producers, of lactic acid when 
the glucose concentrations fall below the threshold, which suggests 
that glycolysis is the cells' defense against a high influx of 
glucose. Gorozhanskaya and associates (19) found negligible 
amounts of oxygen and high content of carbonic acid in their study 
of malignant effusions. Fandy and Kaplan(16) found that synthesis 
of M subunits (LDH-5) is stimulated by low oxygen tension and 
synthesis of H subunits (LDH-I) was not affected. 
Vesell's (77) discovery of predominance of LDR·-l in mature 
human erythrocytes (which are highly anaerobic tissue cells) was 
in contradiction with the above mentioned hypothesis and led to 
the formulation of a second theory (78) consistent with the first, 
but more general, holding that each LDR isoenzyme fulfills dis-
tinctive roles by virtue of its restriction in various regions of 
the cell. Subcellular localizaion of the isoenzymes depends on 
their different kinetic properties, as well as on the metabolic 
organization of the particles with which they associate. (4) 
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Table I in the auuendix is an attempt to sumarize various 
workers' demonstrations of the heterogeneity of LDll activity in 
human tissues. Figures 3 and 4 illustrate the findings of one 
worker in his investigations of serum and tissue LDH isoenzyme 
patterns (88)" 
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Figure 3. LDH isoenzyme 
composition of watery ex-
tracts of normal human 
tissues.(After Wroblewskj 
and Gregory) (88) 0 
Heart muscle is characterized by a predominance of LDH-l, fol-
lowed in order by LDll-2, LDH-3, LDH-4 and LDH-5. Liver shows a 
preponderance of LDH-5 followed to a much lesser extent by LDH-4, 
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LDH-3, LDH-2 and LDH-I. Skeletal muscle resembles liver in its i80-
enzyme pattern. Kidney shows a co-dominance of LDH-l and LDH-2, 
followed by LDH-3, LDH-4 and LDH-5. Lung exhibits prevalence of 
LDH-~ and to a lesser extent LDH-2 and LDH-4 are seen. Pancreas 
shows a predominance of LDH-3, followed closely by LDH-l and LDH-2. 
In granulocytes LDH-5 predominates. Erythrocytes are richest in 
LDH-l and LDH-2. Starkweather and associates (67) found large 
amounts of LDH-5 are associated with the erythroblast nucleus, and 
gradually decreasing quantities of this isoenzyme as the cell mat-
ures; thus LDH-5 may be a measure of erythrocyte age. Prostate, 
prostatic fluid, bone marrow, thyroid, adrenal, spleen, brain, cer-
vix, skin and stomach isoenzyme patterns are also presented, and 
the reader is referred to Table I in the appendix for these isoen-
zyme patterns as well as the literature references of each. 
'Normal human serum exhi bi ts a predominance of LDH-2 (37-55% 
of total LDH activitY/' followed in descending order by LDH-l 
(23-45%), LDH-3 (8-24%), LDH-4 (1-8%) and LDH-5 (0-4%). For more 
details refer to Table I in the appendix.(25,43,59,74,75,85,87) 
A normal diurnal variation has also been demonstrated by Stark-
weather and associates (70) as shown in Table II of the appendix. 
Here they found a general rise in total LDH activity from the 8 A.N!. 
B. A., 50, if. Normal adult 
Total plasma LD = 300 units I ml. 
>-
i rJ ...... -----'-c=J-........ -~a.::.::.::;.::.::;a.-.~~---I.~~ 
a. - LD~ LDJr LD3 LDZ 
Plasma isoenzymes of lactic 
.~ehydro9.enase 
Figure 4. Serum L~H isoen-
zyme composition of a nor-
mal individual. (After Wro~­
lewski and Gregory)(88)& 
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basal state; ryeak total activity (double the basal rate) occurred 
at 6 P.M., as did LDH-5, while LDH-l activity was at its lowest 
level at this time. LDH-2 changes paralleled those of LDH-I; LDH-3 
and LDH-4 were much less affected. 
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ALTERL'i.TIONS IN THE NORMAL SERUM ISO''';NZYFE PATrl'ERN 
Enzymes are proteins and as such, are synthesized in their cells 
of origin from amino acids, and somehow find their way into the 
plasma. Analysis of plasma, serum or tissue homogenate is not car-
ried out to determine the amount of an enzyme in terms of weight, 
but rather the activitl of the enzyme is determined. Besides being 
dependent upon the method of assay, this measured activity is also 
dependent upon tll" .\:Jresence, absence, or rela ti ve concentrations of 
inhibitors, activators, co-factors, substrate, and finally the 
enzyme itself. Therefore, any alterations in the activity of the 
enzyme may be due to alterations in anyone or more of these factors. 
Normal breakdown and turnover of tissues is thought to contribute 
to most of the enzyme activity in normal serum.(4) Figure 5 111u8-
trates the factors influencing measured serum enzyme activity. 
FACTORS INFLUENCING 
MEASURED SERUM ENZYNfE ACTIVITY 
ENZYME DEGRADA.TION ENZYME FQRMATION 
~ ENZYME LEVEL IN CELL ~ 
CONCOMITANT PERMEABILITY OF SPECIFIC 
i DAMAGE TO ----....;)~ CELL ~ftEMBRANES< "'IIi1:'.----- TISSUE 
OTgER TISSUES ~ INJURY 
EN ZYME LEVEL IN SrmUM. 
ELIl'HN ATION IN 












Figure 5. Factors influencing measured serum enzyme activity. (Mod-
ified from Batsakis and Hauss.)(4,23) 
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Alterations in cell membrane permeability aupear to playa large 
part in enzyme release. Permeability can be varied physiologically, 
and changes may be reversible or irreversible.(4) 
Tissue injury has long been known to result in serum enzyme 
elevations, and on the surface it would appear easy to attribute 
these elevations to the altered membrane permeability resulting from 
the in,jury. That other factors may have an important effect on 
serum enzyme activity puzzled Wroblewski in 1958 (93) and later (91) 
he used the example of glutamic oxaloacetic transaminase (GOT) in 
cardiac tissue to present his point. He agreed that the high activ-
ity of human cardiac tissue compared with the relatively lower ac-
tivity of an equivalent weight of serum appears to explain in part 
the observed significant elevation of serum GOT values after myo-
cardial infarction. However, not all enzymes present in large 
amounts in the cardiac tissue as compared with equivalent amounts 
of serum are noted to increase in the serum of patients experien-
cing myocardial infarction; i.e. tributyrase and cholinesterase. 
Experimants with intravenous injection of GOT and LDH into dogs 
results in a rapid rise in serum GOT and LDH values, with a return of 
these enzyme activities to normal within 1-4 hours. In the case of 
LDH, when serum enzyme activity rises to ten times that of normal, 
it returns to normal range of serum activity in 1 hour. At this 
rate of serum enzyme degradation and/or elimination, the LDH content 
of the infarcted heart muscle would not appear to be sufficient to 
maintain the serum enzyme activity level at 3 to 6 times normal 
serum value for a period of 5-7 days. Human cardiac muscle con-
tains ap;Jroximately 250, 000 units of LDH/ gm. of wet tissue; with 
comparable techniClues the serum contains approximately 400 units/Illl. 
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One gram of heart tissue would cause an LDH activity of 100 units/mI. 
in 2.2 liters of serum. An LDH increase o~ 1500 units/mI. often 
observed in patients with myocardial infarction presupposes the nec-
rosis of 15 gm. of cardiac muscle. In order to maintain a serum 
level of 1500 uni ts/ml., 15 gm. of heart muscle would have to be 
destroyed per hour, or 360 gm. /day. If the serum LilH level were 
maintained at about 1500 units or more for 3 days, which is seen 
frequently clinically, 10SO gm. of heart muscle would be required, 
whereas a normal heart weighs only about 300 gm. Thus some other 
mechanism must be involved to account for the prolonged enzyme 
elevations seen. 
The report of Hill (27) in 1954 of elevated LDH serum levels 
in neoplastic disease has led to investigations of the mechanism 
of such an elevation.(3,4l,47,4s,62,81) Mahy (41) reports earlier 
workers presented evidence that enzymes are removed from the blood 
by the reticuloendothelial system. His work and others'(3,62,4s) 
with mice infected with certain strains of Riley virus showed that 
the resultant LDH serum elevations were most likely due to decreased 
clearance rates from the ~asma. The possibility that in other 
disease states the enzyme serum clearance rate may be decreased 
certainly is worthy of some consideration. 
The role of necrosis in enzyme elevation was further studied 
by'Hroblewski (93) and';Iest (81). They both found increased levels 
of LDH in the absence of necrosis of malignant tumors in rats, 
suggesting that increased synthesis, altered membrane permeability 
or some other factors must ~lay a role in the elevation of LDH. 
Hause (23) has reported that enzyme elevations in cases of 
surgery, infectious diseases, and nulmonary 6mbolism react in the 
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the same manner as in myoc::lrdial infarction; quantitative and tem-
poral differences may exist~ but the reaction remains the same--
nan-specific. These enzyme changes occur along wi tIl other comrilon 
non-specific symptoIDs--rise in temperature, leukocyte increase~ 
changes in the CBC, serum protein, UA, increased erythrocyte sed-
imentation rate, blood sugar and rest nitrogen elevation and other 
symptoms which together Hauss has termed the Ilacute syndrome. 1t 
If the foregoing is true, if there are so many variables to 
consider to account for serum enzyme elevations, can any clinical 
use be made of enzyme determinations? tlTroblewski (89) speaks well 
to this question: IlMost if not all enzymatic reflections are non-
specific in that more than one etiologic factor and more than 
one anatomic site can account for similar quantitative and or 
serial enzyme changes. In addition, the multiplicity of enzymes 
present in body' fluids, as well as the influence of other body 
fluid constituents, such as inhibitors, antienzymes, activators, 
competitors, drugs and others, may account for apparent artefacts 
included in the extensive enzyme activity of the body fluid. 
However, the concomitant measurement of several enzymatic activ-
ities and clinical correlation makes it possible at times to pin-
point the type and site of a pathologic process. In addition, in 
some instances, serum enzyme changes have permitted recognition 
of disease such as hepatitis in the prodromal phase of the malady; 
in other instances, such as drug toxiCity, serum enzyme alterations 
have indicated pathologic effects at a time when other labOratory 
parameters have been uninfl1Jenced; in the case of suspected myo-
cardial infarction associated with bundle branch block of other 
masking electrocardiographic aberrations, serum enzyme changes may 
18 
contribute pivotally to the resolution of the diagnostic problem. 
The use of body fluid enzymes to supplement cytologic techniques 
is an addition to the armamentarium for the study of patients with 
oncologic diseases •..•. " 
19 
LDH ISOENZYME .~LTERATIONS IN DISEASE STATES 
Initial enzymatic studies in disease states showed gross 
elevations in LDH, SGOT, and others. (92, 83, 82, 47, 79, 74, 63, 
31, 30, 28, 24, 6). As was stated before, all organs contain 
LDH, and organ injury produces an elevation in serum LDH; how-
ever, this elevation is non-specific. Cohen (10) proposed that 
if some characteristic feature of LDH could be identified that 
would betray its source, the locus of specific organ injury might 
be established. With the discovery of the multiple molecular 
forms of LDll, identifiable by electrophoretic separation, heat 
fractionation, and other means, such a characteristic feature was 
found. Cohen's work, plus that of others discussed below, showed 
that the serum pattern of LDll isoenzymes following organ injury 
is usually characteristic of that organ. 
20 
ISOEN'ZYMES AND NfYOCAI-mIAL INFARCTION 
Cardiac muscle has a predominance of LDE-l and 2, and thus 
injury to this tissue results in increases in serum LDH-l and 2. 
This increase has been noted within hours (87, 90, 91) of the 
onset of the acute attack, is maximal before the fifth post-
infarction day, and remains elevated for 5-10 days after all 
total plasma enzyme activities have returned to normal range. 
(87, 90) Typical serum LDH isoenzyme patterns in patients with 
acute myocardial infarction are reported by Reusch and Bunch (59) 
as shown in Table III of the appendix. In all there was a 
predominance of LDH-l. In two cases SGOT and total LDE changes 
were subtle, but isoenzyme analysis clearly demonstrated a shift 
from the normal predominance of LDH-2. 
Wroblewski and associates (90) demonstrated the serial LDH 
isoenzyme changes in acute myocardial infarction as shown in 
Table IV of the appendix. They presented two patients whose LDH-l 
abnormalities persisted for 19 and 20 days. These abnormalities 
are further illustrated by the report of Nutter and associates (49). 
See figure 6. 
SERIAL CHA.NGES IN LDH-l TN ACUTE MYOCARDIAL INl<'ARCTION I 
Day 1 2 3 4 5 6 7 8 9 10 11 
Subjects 8 18 22 22 23 22 22 '22 18 16 12 
Abnormal 5 17 22 22 22 22 21 21 17 15 10 
Normal 3 I 1 0 0 1 0 1 1 1 1 2 r-- ! ! 
Figure 6. Data showing serial LDH-l changes in acut'e myo-
cardial infarction. (After Nutter)(49). 
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starkweather (70) studied LDH levels serially on 25 con-
troIs monthly for 9 months and found insignificant variations in 
individual enzyme levels even though a wide range of activity was 
• observed for the group. Therefore it appeared to him that normal 
serum LDH ranges as derived from statistical data could lead to 
erroneous clinical interpretati~n. For example, if a person with 
a normal LDH level of 0.192 units shows a level of 0.384 units, 
statistical data would place it within normal range when actually 
a two-fold increase has occurred. Since baseline determinations 
are usually not available, he proposes one should get three fast-
ing samples and evaluate the changes. The examples in figure 7 
illustrate this point. 










Figure 7. Chart show"ing small but significant isoenzyme changes 
from base line levels. (After Starkweather)(70). 
In some instances, myocardial infarction may not be accom-
panied by diagnostic serum enzyme changes, but analysis of the 
LDH isoenzyme pattern helps pin down the diagnosis, as illustrated 




Figure 8. Case illustrating insignificant total LDH changes 
but significant isoenzyme alterations. (After Van Der Hel~74). 
The serial determination of LDH isoenzymes may also be of 
help in diagnosing myocardial infarction which has occurred 
several days before medical attention is sought, as illustrated 
by figure 9. (74) 
Acute Attack 8 Days Before Rosuital Admission 
9 
12 
Figure 9. Chart showing LDR isoenzyme alterations in a patient 
suffering a myocardial infarction eight prior to medical attention. 
(After Van Der Helm) (74). 
Thus it would appear from the data presented that prolonged 
changes in LDF-l occur in uatients with acute myocardial infarction 
and that the serial analysis of LDH-l is a sensitive aid in the 
23 
diagnosis of acute myocardial infarction. 
It must be Dointed out that in some cases of acute myo-
cardial infarction, there has been noted a rise in LDH-5; this 
change has been ascribed to the presence of severe congestive 
heart failure, causing increased serum contributions from the 
hepatic cells. (87, 73) 
Of particular importance is the negative value of the "zymo-
II gram. Thus LDH isoenzymes can be used to differentiate between 
myocardial infarction and other conditions not readily distin-
guishable from myocardial infarction. Cardiovascular diseases 
with normal fractions of LDH-l and LDH-2 include: congestive 
heart failure, in all but severe cases,; acute pericarditis; 
paroxysmal atrial fibrillation with stenocardia; chronic angina 
pectoris, heart block with Stokes-Adams seizures; acute venous 
thrombosis of the lower extremity; and pulmonary embolism. (74, 
87, 11, 73) 
Starkweather and associates (70) attempted to prognosticate 
the clinical course of the patients with myocardial infarctions 
on the basis of enzyme studies. They found that there was no 
correlation between serum LDH levels and mortality •. They did, 
however, find some relationship with survival and an elevation 
in LDH-5 within 24 hours post-infarction_" Twelve such individuals 
exhibited a rapid rise in that fraction within 24 hours and did 
not recover from the attack. It is usual to attribute such rises 
in LDH-5 to some degree of congestive heart failure; however in 
these twelve patients, post mortem examination showed no con-
gestion of the liver, and the source of the LDE-5 was not found 
in these cases. 
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Although the agar gel electrophoresis method of determination 
is the one used by a great number of workers, it is somewhat 
cumbersome. Wroblewski (88) realized this early and proposed 
a simple heat-stable test for determination of LDH isoenzymes. 
This determination takes advantage of the fact that different 
LDH isoenzymes have different thermolability properties •• lso-
enzymes which migrate electrophoretically with the gamma glob-
ulins are relatively thermolabile ••• lsoenzymes which migrate 
toward the anode (rapidly migrating) are relatively thermostable. 
LDH which remains after incubation at 65° C for 30 minutes has 
been defined as "heat stable LDH" and represents LDH-l activity. 
This quick method of isoenzyme determination in the diagnosis 
of myocardial infarction has several proponents. (5, 71, 88) 
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ISOENZYMES Hi BEP1\.TIC DISEASE 
HEP./\.TITIS ''lieme and Van Maer-eke (85) noted elevations in 
rat sera of LDH-5 after experimental induction of liver necrosis 
with carbon tetrachloride. Trujillo and assooiates (73) noted 
in four cases of infectious hepatitis an elevation in total LDll 
in all, elevated LDH-5 in all, elevated LDE's 2, 3, 4 in two of 
the four, and no abnormality in LDH-I. Vesell (77) noted most 
of the LUH activity in sera of patients with hepatitis was in 
I,DH's 4 and 5. 1Jfatoole and Novak (43) found in the stud;,\, of four 
cases of acute infectious hepatitis an elevation in LDH's 4 and 
5. Cohen (10) reports an LDll isozymogram in a oatient with 
hepatitis: LDH-l=18%; LDH-2=27%; LDH-3=9%; LDH-4=8%; LDH-5=38%. 
CIRRHOSIS Matoole and Novak (43) studied 35 cases of Laennec's 
cirrhosis and found the most frequent enzyme alteration to be 
elevations in LDH's 5 and 4. Trujillo and associates (73) found 
LDH-I elevations in 9 of 15 patient s with cirrhosis, and J,Dll-l 
elevations in 2. 
BILIARY OBSTRUCTION Wright and associates (87) studied 10 
patients with biliary obstruction and found absolute increases 
in LDll-4 and LDll-5 with the elevations of LDH-4 being greater than 
those of LDll-5. This is in contrast to the marked relative in-
creases in LDH-5 seen in hepatocellular damage. Trujillo and 
associates (73) and :N1atoole and :Novak (43) merely found elevations 
in LDH-5 or LDH's 5 and 4. 
HEPATIC METASTASES AND 1° HEPATOMA In 14 cases of hepatic 
metastases and 1 case of 10 hepatoma, Trujillo and associates (73) 
found elevated total LDll in 14 of 15, elevated LDH-5 in all 15, 
elevated LDH~2, 3, 4 in 12 of 15, and LDH-l elevations in 10 of 
15. In all the :9redominant isoenzyme was LDH-5. 
Thus, in most cases of liver disease studied the LDH ab-
normality most often encountered was that of elevation of the 
predominant isoenzyme found in hepatic cells, LDH-5. 
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ISOENZYMES nr PULMONt:cRY E!,;LBOLISM 
In 1961 Wacker and associates (19) 'oroposed a !!triad for 
the diagnosis of pulmonary embolism and infarction" which in-
cluded serial measurements of serum LDH, SGOT, and bilirubin. 
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In 11 patients they renorted consistently elevated LDH, and 
consistently normal SGOT in the first four days nost embolism. 
Twelve of the 17 had significantly increased bilirubin. Batsakis 
and Briere (4) also reported consistent elevation of serum LDH 
in patients with pulmonary infarcts, but could not improve diag-
nostic accuracy with concomitant serial determinations of SGOT 
and bilirubin. They noted that pulmonary emboli in a hospital 
population usually occur as complications of some other disease 
and the associated disease not infrequently influences enzyme 
levels. Their most successful method of diagnosis of pulmonary 
embolism was with the use of CPK (creatine phosphokinase) deter-
mina tions o.r',DH isoenzyme determinations. Isoenzyme; al terations 
included an increased total activity pattern and a relatively 
greater prominence of LDH-3. These changes were attributed to a 
combination of effects of hemorrhage (LDH-l and LDH-2) and pul-
monary necrosis (LDH-3). On the second day following infarct, 
the majority of patients studied also showed an increase in LDH-5 
related to accompanying congestive heart failure and anoxemia of 
the centrilobular portions of the liver. 
Tru~illo and associates (73) studied 26 patients with pul-
monary embolism and found normal total LDH in H3 patients, and 
only minimal increases in the remaining eight. However, he did 
find alterations i"1 ~}Oe LDH-2, 3, 4 fraction. (Their method of 
LDH isoenzyme determination involved heat fractionation in 'i'lhich 
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the activities of LDH-2, 3~ and 4 could not be differentiated.) 
See figure 10. 
I SERIAL EIi;ZYflIiE CHANGES IN PUHIOlJARY EJVIBCrliISNI 
Day 1 2 3 4 5 6 7 8 I 9 10 11 ! 
Ho. Subjects 3 12 19 23 25 24 26 25 124 221 15 
LDH-l Abnormal I 2 4 8 3 2 7 t::; 7 6 4 J 
LDH-2,3,4 Abn. 2 5 10 8 8 12 12 16 12 11 I 7 
12 10 ; 11 12 12 8 6 
I 
JDH-5 Abn. 1 3 9 12 ! 
j ~ I 
Figure 10. Daily enzyme data in 26 patients with uncomplicated 
pulmonary embolism. (After Trujil1o)(73). 
Although the data from this study do not demonstrate high-
ly consistent LDH-2, 3, 4 alterations, these workers found the 
main value of LDH isoenzyme determinations in pulr:lOnary embolism 
to be the ability to exclude myocardial infarction and to appraise 
other disorders as possible sources of enzyme alteration. 
Cohen and his workers (11) studied 19 cases of pulmonary 
embolism. Twelve of those were found to have normal serum total 
L1JH; four of these had elevated LDH-I, and eieht were normaL 
Seven had elevated serum total LDH; three had elevated LDH-3; 
three had elevated LDH-l and 2, and one had elevations of LDH-
1,2, and 3. They concluded that the LDH abnormalities that 
developed appeared to be related to associated disorders of the 
liver or heart. 
From the above it would appear that pulmonary embolism may 
or may not be accompanied by elevations in total LDH or LDH-3, 
but that the main use of LDH isoenzymes would be to exclude myo-
cardial infarction. 
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LDH ISOENZYJ\IES IN ANEMIA 
In 1958 Zimmerman and his workers (95) reported elevated 
serum levels of LDH in patients with megaloblastic anemia, sickle 
cell disease, hemoglobin S-C disease, S-thalassemia, and Hemoglobin 
A-S or A-C disease. These alterations were thought to represent 
hemolysis, hepatic necrosis, or inherently high LDH concentrations 
in primitive marrow cells. 
Wright and associates (87) studied four patients with un-
treated pernicious anemia, 1 with paroxysmal nocturnal hemo-
globinuria, 2 with sickle cell anemia, and 1 with idiopathic hemo-
lytic anemia, and found almost equal absolute increases in LDH-l 
anct I.DH-2 and a concomitant reduction in the remainder of the 
fractions. This pattern is similar to patterns of red blood cell 
hemolysa tes reported earlier. !J.'hus it would appear that any 
hemolytic process would result in increases in LDH-l and LDH-2 
in the serum. 
Starkweather and associates (67) reported large amounts of 
LDH-5 were associated with erythroblast nuclei, and that grad-
ually decreasing amounts of this enzyme were found as the cells 
matured, suggesting that LDH-5 may be an indicator of erythrocyte 
age; the LDH in aged erythrocytes was found to be LDH-l. They 
propose that when erythrocyte isoenzymes from patients with 
hematologic disease are assayed, increases in LDH-5 indicate ac-
tive or hyperactive erythroid tissue, and absence of this fraction 
suggests nonfunctioning tissue. An increase in the relative per-
centage of LDH-l suggests the presence of an older cell popUlation. 
Heller and co-workers (24) studied serum isoenzymes in 
patients with megaloblastic and blood loss anemias and found evi-
dence to supnort the hypothesis that the high plasma levels of 
enzymes originated in the bone marrow. 
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Thus, in the presence of hemolysis there are elevations of 
LDH-l, in megaloblastic or hyperplastic marrow conditions there 
are elevations of LDH-5, and in aplastic marrow conditions there 
is essentially no LDH-5. 
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ISOENZYIViES IN MUSCULAR DISORDE-qS 
Normal skeletal muscle has a predominance of LDH-5 and thus 
one would predict some alterations of this enzyme in skeletal 
muscle disorders~ Wright and associates (87) report marked 
transient increases in LDH-5 in nine patients suffering crush-
ing trauma, hip fractures, or undergoing extensive surgical 
procedures involving muscle. 
The effect of exercise on the serum enzyme composition 
was studied by Swaiman and Award (72). It was postulated that 
heavy exercise would result in muscle cell damage which in turn 
would result in enzyme release. However, after studies on 11 
men during and after strenuous and prolonged exercise, only 
slight increases in aldolase, CPK, SGOT, and LDH were found, 
and in some no changes or even decreases in enzyme activity were 
found. 
Starkweather and associates (69) studied the effect of 
artificially induced hemostasis by placing a tourniquet on the 
patient's arm for five minutes, after which blood was with-
drawn and a three fold increase in LDH was found. Fifteen 
minutes after the pressure release, the serum LDH had almost 
returned to base line levels, but an elevation in LDH-5 remain~d. 
Emery (15) studied carriers and patients with Duchenne type 
pseudohypertrophic muscular dystrophy. He found no significant 
differences in the serum LDH isoenzyme patterns between healthy 
children and affected children; also he found no differences 
between normal women and carriers. However, the LDH isoenzyme 
pattern of muscle extracts from affected children was very 
different from the controls. LDH-5 appeared to be completely 
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absent; this was true in all sta?8S of the disease irrespective 
of the grade of severity. 
Brody (8) ancl Kelly and associates (36) also re?:)orted find-
ing virtually no LDH-5 activity in sera of pattents with Duchenne-
type muscular dystrophy_ However, Brody studied many muscular 
and neurologic disorders. His findings are summarized in figure 11. 
LDH-5 ABNORIVLil.LITIES IN VARIOUS lIiWSCULAR AND NEUROLOGIC 
DISORDER.S 
Clinical Diagnosis No. of Patients Total l~o. 
wi th Decreased of 
LDH-5 Patients 
Muscular Dystrophy 12 32 
Amyotrophic Lateral Sclerosis 6 51 
Infantile Spinal Muscular Atrophy 5 5 
:Myotonic Dystrophy 4 8 
Idiopathic Inflammatory Myopathy 4 18 
Dermatomyositis 1 4 
Peripheral Polyneuropathy, Idiopathic 3 22 
Diabetic Polyneuropathy 1 6 
Neuromyopathy(?) Due To Carcinoma 1 3 
Spinocerebellar Degeneration 2 7 
Charcot-:Marie~Tooth Disease 2 18 
Benign Congenital Hypotonia 1 3 
Motor Retardation 1 1 
Figure 11. Summary of LDH-5 abnormalities in various muscular 
and neurologic disorders studied by Brody (8). 
He found the selective decrease in LDH-5 is not restricted 
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to patients with muscular dystrophy, but may also be seen in 
other myopathies and in diseases primarily affecting neurons. 
Acquired as well as hereditary disorders were found to be associ-
ated with this phenomenon. Therefore a decrease in LDH-5 is not 
diagnostic of a particular disease entity, it does not differentiate 
primary lesions of muscle from neurologic lesions, and it is not 
indicative of a hereditary rather than acquired disorder. This 
study did indicate, however, that a deficiency of muscle LDH-5 
constitutes a sign of nonspecific abnormality in the neuromuscular 
system. 
The mechanism for this decrease in LDH-5 in abnormal muscle 
has not as yet been adequately explained. Brody (8) suggests 
two hypotheses. The observation that the activity of the fast-
moving isoenzymes is preferentailly decreased in the presence of 
excess lactate suggests that a function of the slow-moving i80-
enzymes may be to maintain activity in the presence of accumulated 
lactate. Thus the slow-moving isoenzymes participate primarily 
in anaerobic (glycolytic) metabolism and the fast moving isoenzymes 
participate in aerobic metabolism. Since the experimental de-
nervation in animals has produced earlier diminution of the glyco-
lytic than of the oxidative enzymes, it may well be that the 
selective reduction of LDH-5 in abnormal muscle may coincide with 
the selective reduction of other glycolytic enzymes. 
A second hypothesis (8) is based on the observation that the 
isoenzyme pattern of normal human fetal muscle also shows a 
selective deficit of LDH-5, and that it is possible that low LDH-5 
activity in abnormal reflects persistence of or a reversion to a 
primitive stage of metabolic adjustment. 
ISOENZYhlES IN DISORDERS OF THE GASTROIhTESTINA1 TRACT 
Hendrich and Hule (25) studied the serum LDH isoenzymes 
of 16 patients with ulcerative colitis and found no substantial 
difference from the group of 55 controls. Homogenates of speci-
mens of rectal mucosa from 8 patients during the acute phase of 
ulceration showed high levels of 1DH-5, while specimens of 4 
patients in the healing stage or remission showed lower 1DH-5 
values. 
Prochazka and associates (54, 55) have done work on experi-
mental lesions of the stomach in rats. In rats with stress in-duced 
ulcers, they found increased total LDH activity, as well as 
elevated LDH-l,2,3, and 4 with decreased 1DH-5; all of which could 
not be explained. They also performed isoenzyme determinations 
on tissue homogenates of normal fundic mucosa, fundic mucosa with 
moderate gastritis, fundic mucosa with extensive gastritis, marginal 
mucosa of the pyloric peptic ulcer, gastric carcinoma tissue, and 
normal pyloric mucosa. They found progreSSively decreasing amounts 
of 1DH-l in the categories previously listed, and found progress-
ively increasing amounts of 1DH-5 in the same categories respec-
tively. 
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LDH ISOEN:6YMFS IK NEOPLASTIC DIS}~ASE 
With the massive amount of research being carried out in 
the field of cancer, it is not surprising that a great deal has 
been published about LDH isoenzymes by its researchers. 
Until Hill and Levi published an article in Cancer Research 
in 1954, (27) the authors had not been able to find any report 
of a study of LDH'activity in human serum. These authors noted 
in a study of 51 patients with neoplastic diseases that 49 of 
them had elevation of a serum comuonent which catalyzed the 
I ~ 
oxidation of reduced DPN and the simultaneous reduction of 
pyruvic acid to lactic acid; in other words, the serum component 
referred to as LDH. White (83) also noted this elevation in 
patients with neoplastic disease, and found that it was more 
consistently elevated in such patients (16%) than was phos-
pbohexossisomerase (48%), aldolase (35%) or SGOT (31%). Most 
people in his group with high serum LDH activity had obviously 
widespread cancer. Although Hill (28) later could not sub-
stantiate his earlier findings, the consensus remained that serum 
LDll activity was elevated in cancer patients. (6, 18, 82, 34) 
In 1957 Vesell and Bearn (76) subjected sera of normal and 
"abnormal" patients to starch gel electrophoresis and found three 
peaks of LDH activity corresponding to the alpha-I, alpha-2, and 
beta serum protein peaks; in three cases of leukemia studied, all 
showed elevation in alpha-2 activity relative to the alpha-l peak. 
Hsieh and associates (30) demonstrated a d.ecrease in serum LDH 
activity in mice bearing squamous cell carcinomas or rhabdomyo-
sarcomas after removal of such tumors, and noted a rise in serum 
LDH in the group where the tumors recurred. 
The question then arises, what causes the elevated serum 
LDH activity in patients with cancer? Jacobson and Bishio (33) 
proposed four hypotheses for the origin of elevated LDH in patients 
with cancer: 1) Volume of the tumor reached a critical size such 
that the rate of LDH production by the tumor cells was higher 
than the normal rate of removal of this enzyme; 2) The tissue 
cells which were replaced by the tumor were ruptured or in some 
way altered so as to release IDH and other com;Jonents into the 
circulatory system; 3) The behavior of normal tissues may be 
affected in some manner leading to a release and/or increased 
synthesis of the LDH normally present in the organ; and 4) A 
factor or virus is often associated with the transmissable tumors 
and causes an abnormally high LDR. Th'ese hy:potheses have been 
sunported in whole or in part by other workers (3, 48, 62, 41, 93, 
69). 
~at kind of LDH is produced by these tumors? Richterich 
and Burger (61) compared isoenzyme patterns of benign and malig-
nant effusions and found that: 1) In benign effusions (transudates 
or inflammatory exudates) the isoenzyme pattern reflected the 
serum pattern and the activity of the slowly migrating isoenzymes 
was low; 2) In malignant effusions the electrophoretically slowly 
migrating fractions were elevated in comparison to the correspond-
ing sera; and 3) The activity of the slowly migrating fractions 
was markedly increased independent of the type of malignancy 
(carcinoma of the lung, eso:phagus, pancreas and breast; hyper-
ne)Ll'OLLC, reticulosarcoma). 
That a high rate of glycolysiS is characteristic of tumor 
tissue has long been estab1ished (18, 19, 20). Ascites fluids 
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in cancer patients have been found to have a high content of 
carbonic acid, negligible amounts of oxygen , and lactic acid 
concentrations two or three times blood levels indicating large 
amounts of pyruvate reduction. Thus, ascttes cells in cancer 
cases were found to exist under nearly anaerobic conditions. (19) 
/ 
! 
Goldman and associates also found a predominance of, ltDH-5 in 
cancerous tissues. They reported that earlier workers indicated 
that the only pathway in malignant tumors for non-rrlitochondrial 
oxidation of reduced NAD formed from the oxidation of triose-
phosphate may be through pyruvate reduction, and that there appear-
ad to be a change in LDH type to an enzyme which is geared for 
pyruvate reduction. Goldman further states that the slowly mi-
grating LDH (M-LDH or LDH-5) nis better able to convert pyruvate 
to lamtate in the presence of high pyruvate concentration, thus 
sustaining glycolytic activity through the replenishment of NAD, 
which is required as a hydrogen acceptor in the earlier oxidation 
of triosephosphate.: 
Studies of tissue homogenates of various carcinomas have 
demonstrated this shift in isoenzyme pattern to increasel amounts 
of LDH-5. Carcinomas studied include those of rectum, colon, 
breast, stomach, lung, prostate, kidney, and thyroid, as well as 
astrocytomas and malignant tumors of glial origin. (10, 14, 16, 
53, 61, 66) Studies of malignant effusions also showed this shift. 
(22, 61) studies of leukocytes in chronic lymphocytic leukemia 
and chronic myelogenous leukemia produced different results; 
l:.rmphocytes exhi bi ted relatively low levels of LDH-5 acti vi ty (7. 
3%), whereas granulocytes exhibited high levels of this isoenzyme 
(24.1%). Some workers (68, 87) have found isoenzyme alterations 
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of LDH-3 to be the greatest, both in tissue homogenates and in 
sera of patients with neoplastic disease. The only instances of 
LDH-5 alterations were in demonstrated cases of hepatic metastases; 
when these metastases were shown to be absent, only LDH-3 was 
elevated. However, the majority of workers feel that the main 
alteration appears to be in the LDH-5 fraction. 
Clinical application of LDH isoenzymes in patients with new-
plastic disease is useful in several areas. Malignant effusions 
demonstrate elevated LDH-5 act~vity and can thus be differentiated 
from benign effusions. (60, 61) Following chemotherapy or radiation 
therapy, analysis of the effusion could be of prognostic value; 
decreases in LDH-5 would indicate effectiveness of the therapy, 
and no change or increases in activity of this isoenzyme would 
indicate ineffective therapy. (19) 
starkweather and associates (69) attempted to correlate 
enzymatic aberrations with clinical evaluation of disease. Their 
results are summarized below: 
: Extent of Disease--Clinical vs. Enzymatic Classification 
i~---------1~R~f:;1c~~~y~~:a~r6n_i-N;;~~r -. 
Clinical I Total LDH and iso- ' Isoenzyme patj Total LDH & Iso, 
i Classificati0nl enzyme pattern(27) tern only(12)1 enzyme pattern(ql 
L·-"-"-----'"--·-'---"-----·--"l---"---~------~ "-"--- ! .. -------"---,----------
I 
/ Extensive ! 25 10 4 
Limi ted I 2 2 
None of the patients with abnormal total serum LDR demonstrated 
normal isoenzyme patterns. In the four "clinically extensive" 
but enzymatically normal patients, the enzyme nattern became 
abnormal within five days to four weeks after admission to the 
39 
study. Thus, the use of such ~arameters as a screening test for 
the early detection of neoplastic disease does not appear to 
possess adequate sensitivity to be of clinical use. 
Elhilali and associates (14) nroposed the use of LDH 1so-
enzymes in the differentiation of hyperplasia and carcinoma of 
the prostate. Prostatic fluid was examined and prostatic tissue 
frDm transuretbral resection, prostatectomy and needle biopsy were 
obtained. A shift to slower migrating isoenzymes was demonstrated 
in tissue specimans from patients with carcinoma; only normal pro-
static fluid isoenzyme levels were established, although in three 
cases of carcinoma studied, the isoenzyme patterns were abnormal. 
Since it is estimated that 95% of the patients with carcinoma of 
the postate are disgnosed too late for operative treatment, an 
earlier method of detection would certainly be advantageous. Such 
a method is proposed; that is a screening test which would involve 
a study of the LDH isoenzymes of prostatic fluid. In cases of 
early carcinoma this would be practical, however in advanced 
carcinoma of the prostate, fluid is difficult to obtair .• Another 
apnlication of LDH isoenzymes would be to monitor changes in the 
sera of patients with advanced carcinoma under treatment as an 
index of the efficacy of that treatment. (14) 
Starkweather and associates (69) proposed the determination 
of LDH isoenzyme responses following therapy for neoplastic disease 
as a prognostic guide. Also proposing this plan were many others. 
(47, 7, 94) Of 21 patients who showed a decrease in the isoenzymes 
complement (ascribed by those workers to the host's tumor), 12 
improved either objectively or subjectively, 1 was unchanged and 
7 grew worse. 
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'rIlE EFFECT 0:3' OJ=L\.L CONTRACEPTIVr:S ON SERUM El~ZYMES 
Pulkkinen and 'Villman (56) studied 75 women taking estro-
genic, progestogenic, combination, and sequential oral contra-
ceptives and found no difference between that group and a group 
of 30 controls. They found that the total LDH activity in the 
whole groun was decreased; however, estrogenic pills had no 
effect on LDH; the progestagenic pills lowered the activity of 
LDH but did not alte~ the isoenzymes. The duration of adminis-
tration made no difference on the results obtained. Administration 
of a combination oral contraceptive to both men and W(men pro-
duced similar LDH serum changes, i,e, total LDH activity was low-
ered in 1-2 days following initiation of administration. 
RECAPITULATION AND CONCLUSION 
Lactic dehydrogenase which is present in all living cells, 
plays an important role in glycolysis by catalyzing the reversible 
conversion of lactate to pyruvate, producing in the process a 
molecule of' reduced DPN. Most workers believe there are five 
electrophoretically distinct molecellar forms of LDI! otherwise 
known as isoenzymes. Each of the five isoenzymes is a tetramer: 
that is it is composed of fou' subunits. These four subunits 
are of two basic types: the n M II or muscle-liver unit and the "H" 
or heart unit. LDH-I and LDH-5 are homogeneous, containing four 
IIMIl and four !tR" units, respectively, whereas LDH-2, LDH-3, and 
LDH-4 are combinations of the two basic subunits~ 
The techniques used for identifying the LDH isoenzymes have 
included the electrophoretic rate of migration in solid media and 
the relative heat ~bility. Electrophoretic demonstration of 
isoenzyme activity is accomplished by conversion of neotetra-
zolium to purple formazin by LDH production of DPNH. 
Nomenclature is basea upon electrophoretic migration rates, 
with the form having the highest mobility toward~ the anode being 
designated as LDH-I. Thus, the hea.rt fraction is LDH-l and the 
slowest or liver and skeletal muscle fraction is LDH-5. LDH-l is 
more heat stable than the other isoenzymes. This property gives 
rise to a heat stab1e test for isoenzymes which affords separation 
of LDH activity into three categories:LDE-l; L:!2H-2,3,1+; and. LDH-5. 
This activity is determined by measuring the declining optical 
density as DPNH is diminishing and pyruvic acid concomitantly is 
being reduced to lactic acid, or by the increasing optical density 
as the reaction is proceeding in the reverse manner. 
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Each tissue of the body elaborates its own uniaue pattern of 
LDH isoenzymes. LDH-l appears to predominate in aerobically func-
tioning tissues and is more efficient there than is LDH-5; LDH~5 
predominates in aerobically functioning tissues, where it is most 
efficient. 
Heart muscle is characterized by a predominance of LDH-I, fol-
lowed in order by LDH-2, LDH-3, LDH-4 and LDH-5. Liver shows a 
nredominance of LDH-5 followed to a much lesser extent by LDH-4, 
IJDH- 3, LDH-2 and LDH-l. Sl<eletal muscle resem.bles liver in its 
isoenzyme pattern. Kidney shows a co-dominance of LDH-l and LDY"'.z 
followed by LDH-3, I,DH-4 and LDB-5. Lung shows predominance of 
LDH-3, and to a lesser extent LDH-2 and LDH-4 are seen. Pancreas 
shows a predomin.ance of LDH-3, followed closely by LDH-l and LDH-29 
In g-ranulocytes LDH-5 predominates. Mature erythrocytes are rich-
est in LDH-l and LDH-2; nucleated erythrocytes are richest in 
LDH-5. Prostate, prostatic fluid, bone marrow, thyroid, adrenal, 
spleen, brain, cervix, skin and stomach isoenzyme patterns are also 
presented. Normal human serum appears to be richest in LDH-2, 
followed by LDH-l, I,DH- 3, LDH-4, and LDH-5. 
~mny factors influence the measured serum activity of an 
enzyme--some of which are: rate of enzyme formation 2nd degradation 
within a cell; permeability of the cell membrane; rate of degrad-
ation in plasma or elimination in urine and bile; presence, absence 
and relative concentrations of inhibitors, activators, co-factors 
and substrate; and finally, the method of assay--all act together 
to yield the final measured enzyme activity_ 
The serum pattern of LDH isoenzymes following organ injury 
is usually characteristic of that organ. IiiLyocardial infarction 
produces an el.evation in serum LDH-l, which may be demonstrated 
within a few hours of the acute attack, and persists for 5-10 
days after all total plasma enzyme activities have returned to 
normal. Elevations in serum LDH-5 which have sometimes also 
occurred have been ascribed to the presence of severe congestive 
heart failure. LDH isoenzymes can be used to differentiate 
between myocardial infarction and congestive heart failure~ acute 
pericarditis, paroxysmal atrial fibrillation with stenocardia, 
chronic angina pectoris, heart block with Stokes-Adams seizures, 
acute venous thrombosis of the lower extremity and pulmonary 
embolism. 
In most cases of liver disease (including hepatitis, biliary 
and fatty nutritional cirrhosis, biliary obstruction, and hepatic 
metastasesJ the LDH abnormalitj most often encountered was ele-
vation of the predominant isoenzyme found in hepatic cells, LDE~5. 
Pulmonary embolism produces inconsistent LDH-2,3,4 alter-
ations and the main use of LDH isoenzymes would be to exclude 
myocardial infarction. 
Isoenzyme studies in anemia reveal LDH-l elevations in the 
presence of hemolysis, LDH-5 elevations in megaloblastic or 
hyperplastic marrow conditions, and no LDH-5 activity in aplastic 
marrow conditions. 
In muscle disease studies of muscle extracts show only that 
a deficiency of LDH-5 constitutes a sign of some nonspecific 
abnormality in the neuromuscular system. 
In neoplastic disease the bigh rates of glycolysis charac-
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teristic of tunor cells with the concomitant shift to production 
of LDH-5 which is ~ore suited for pyruvate reduction accounts for 
serum elevations of LDH-5 in neoplastic disease. These elevations 
have not been found until the tumor has reached a clinically 
detectable size. Therefore, at present the use of L.Dll isoenzyme 
screening tests for early detection of neoplastic disease would 
not appear to be of value. LDll isoenzyme determinations may be 
useful in several aspects of neoplastic disease, however. Isoen-
zymes may differentiate malignant effu0~ons from benign. 
Efficacy of anti-tumor therapy could be determined by monitoring 
isoenzyme changes. Early carcinoma of the prostate could be 
detected by testing prostatic fluid or needle biopsy speciment. 
Oral contraceptives ap~ear to have no effect on LDB isoen-
zyme patterns, although the total LDH serum activity may be 
reduced by some preparations. 
Fortunately, the applications of LDH isoenzyme determinations 
are not to the diagnostician vvhat penicillin and cortisone were 
once thought to be to the clinician. Diagnosis and treatment of 
ailments of ueop1e have not been reduced to a task capable of 
being carried out by an automated analyzer and a computer. 
Rather, it is a physiCian who, after eliciting a history and 
examining the patient, selects a group of laboratory determinations 
(which in certain instances this paper has tried to show would 
include LDll isoenzymes) which may help him in confirming or 
ruling out his clintcal impresstons; and then attempting to ex-
ulain such results on the basts of those clintcal impressions, 
never losing sight of the :fact that he ts treating a .:2.§-tient 
and not a laboratory result. That is the clinical aD~lication 

































LDH I SOEN 2YM": 1:'A'J'TERNS 
OF NOHlvl11.L HUMAN TIS,3UES 
% 1'C"NL LDH ACTIv~l'Y IN EACH ISOENZYME PEAK 
LDH-1 LDH-2 LDH-3 LDH-4 LDH-5 
73 24 3 - -
48 35 13 3 1 
35 26 ;1.2 16 11 
58 36 3 2 1 
3 8 25 23 41 
1 3 7 12 77 
2 4 11 27 58 
1 3 7 - 74 
- - 5 16 79 
4 7 21 27 41 
14 16 14 7 43 
43 44 12 1 -
33 34 24 7 1 
38 32 15 - -
14 34 35 5 12 
5 13 32 30 20 
6 17 32, 21 11 
37 12 49 2 -
27 32 27 9 5 
32 15 43 - 2 
5 10 16 26 43 
4 15 22 14 Lf5 
43 44 12 1 -
44 39 14 2 -
36 44 15 4 2 
39 56 - 5 1 
12 33 35 18 2 
3 21 48 24 4 
8 23 24 25 20 
4 13 28 30 25 
5 22 35 27 11 
--,--"~-' 
4 18 36 33 9 
5 14 29 32 20 
9 27 33 20 5 
25 29 31 14 1 
8, 57 21 - 8 
- 4 34 37 25 
31 23 25 17 4 
4 15 31 30 21 
31 37 21 7 4 
23 48 18 7 3 
33 47 16 3 2 
32 39 24 3 2 
44 46 8 1 1 
23 55 15 5 1 



















































Summary of serum 
and tissue LDH 
isoenzyme pat-
terns as reported 
in the references 




LDH I SO E}; zniE :)IUT~AL VA~T!\.l'TON : 7~' ) \ ,1J , 
HOUR ··TC)1'ii.L LDH I ;~()~N 2Yx/1ES 
LDH 
units 1 2 5 
.240 27 38 20 8 7 
1000 .312 28 38 19 7 8 
1200 .288 26 
1400 .360 25 
• "" .. _ .... ,< •••• ~.~,_-.~,_."~, H. 
1600 .432 22 
1800 .528 20 31 
2000 .528 19 31 23 10 17 
2200 10 11 
2400 10 9 
0200 d36 8 9 
0400 .336 40 18 8 8 
0600 .250 38 21 7 8 
Table II. LDH isoenzyme diurnal variations in 
a normal individual. (After Starkweather)(70). 
TABLE III 
TYPICAL SERUM LDH I SOEN ZYM}~ PA'r'11ERNS IN 
PATIENTS \VITH ACUTE MYOCARDIAL INJ<"ARCTIONS (59) 
-'"~''"'-''''''''''''''''''''~''.'''"'''''"''''''''''''' 
PATIENT SGOT ISOENZYMES 
units % ". 
3 4 
B.J. 940 3 Tr. 
E.J. 250 7 
E.S. 234 22 
H. :N. 32 8 Tr. 
L.N. 147 37 416 42 9 Tr. 
L.J. 88 22 296 37 1 Tr. 
o. F. 226 30 ; 491 :55 36 9 Tr. 









i ~".'. _J 
Table III. Examples of serum LDH isoenzyme patterns of patients 
with acute myocardial infarctions.(After Reusch and Bunch)(59)o 
48 
. TABLE IV 
r-,.."......_._. __ ~""",","~."-,...."...."....."..""""",=,,",--,,,.,".~ .. ~~."'T" - I 
SERIAL CIH PG""S IN SERmil LDH Isr)E~;zn~ES ; 
.. ~AT IEN~~.JiI1'ILJlg.·c1'"l~" i!rX:Q_C_~~RP.I4b .. ]NlfAE C T LQlL.J.9Q.L ~ 
!Day! LDH f % LDH Isoenzymes I GOT . . ;! r--T---'-;r---3-"-'Ij:--"-"~)""'- -1 . 
- ... """". .... -"'''''_,, ___ ,~ 0 ,4~ ,"",,~."_ ~ -+, .... ,.~ ........ "~~~"t'."'-"hl" "," """., "" "".", ... ~",..,.,., ,,,,~_.,,-,,,,,. ,u. c,.,. ",' ._ ..... __ ~ ....... ~.,-" ..... ~_.,_" ~.,"·--~"""~ .. ~""---~-.... r""-"-.....,--. ....... --"'~,-~ 'fl~ 
Poster:-.',,,.or
T 
i,' 6 I 640! 48 27 10 4 4: 22' 
~al1 . , I 
, - l>u .... \ 8 \ 780 I:j 6 28 1 4 2 14 
Antero-
septal 







11 I 760 30 20 12 1] 0 25 
15 ' 31 ')0 13 7 6 20 
19 : 22 I} 15 q 2. 22 
27 . 18 21 15 3 12 '14 
33 33 9 0 2 
61 20 8 0 1 
39 20 13 0 4 
32 24 20 8 1 
25 22 13 3 0 
44 33 9 3 0 
42 31 11 2 3 
26 29 17 7 8 














Ta ble IV. Examples of serial IJDR isoenzyme changes in 
pa tients with acute myocardial infarction. (After 'Jro-
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